House lawmakers threaten FDA with subpoena amid probe into overseas inspections

Once again, U.S. lawmakers are pressing the Food and Drug Administration for clarity around the agency’s tracking of scarce medicines and foreign inspection priorities.

After contacting the FDA back in July, Republicans on the House Committee on Energy and Commerce are digging into a Bloomberg report stating that the agency has put the kibosh on its unannounced foreign inspection program.